Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma

NCT00006184 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Myeloma Immunoglobulin Idiotype Vaccine
DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Cyclosporine
DRUG: Doxorubicin hydrochloride
DRUG: Etoposide
DRUG: Fludarabine phosphate
DRUG: Prednisone
DRUG: Vincristine Sulfate
DRUG: Methotrexate
BIOLOGICAL: GMCSF (granulocyte macrophage colony stimulating factor)
BIOLOGICAL: GCSF (granulocyte colony stimulating factor)

Sponsor

National Cancer Institute (NCI)